End Hep C SF is a multi-sector collective impact* initiative that utilizes evidence-based practices, community wisdom, and the creative leveraging of resources to work toward hepatitis C elimination in San Francisco. San Francisco has a history of innovative and ambitious public health efforts. End Hep C SF emerges from that history to tackle an epidemic that kills more Americans than the deaths from sixty other reportable infectious diseases, including HIV, pneumococcal disease, and tuberculosis, combined. 

 

OUR VISION 

Vision Statement: End Hep C SF envisions a San Francisco where hepatitis C is no longer a public health threat, and hepatitis C related health inequities have been eliminated.

 

Mission Statement: To support all San Franciscans living with and at risk for hepatitis C to maximize their health and wellness. We achieve this through prevention, education, testing, treatment, and linkage to reduce morbidity and mortality related to hepatitis C.

 

Values:

We have based our work on beliefs that:

  • All people living with hepatitis C deserve access to the most effective treatment.
  • Everyone living with or at risk for hepatitis C should have equal access to prevention and care regardless of individual characteristics, including but not limited to race/ethnicity, insurance status, housing status, gender identity, sexual orientation, age, mental health status and substance use.
  • Our work is most effective when people who have lived experience with hepatitis C are involved in all aspects of planning and implementation.
  • It is imperative to draw on the wisdom of service providers, activists, people who use drugs, and others in the community who have been most impacted and engaged in the fight against hepatitis C over many years.

We are committed to working together to:

  • Provide interventions that are evidence based, and continuously review our progress to determine areas where we need to improve, through the regular collection of and use of local data related to hepatitis C.
  • End stigma about hepatitis C and people living with hepatitis C.
  • Maximize the health and wellness of people who use drugs by treating them with respect, ensuring access to appropriate services, and empowering them to reduce harm and make choices to improve their health.
  • Continue to invest in populations that have frequently been characterized as "difficult to engage," as we realize that these groups often have the greatest unmet need for services and support.



Back To Top